Alpha Tau Medical Ltd. (NASDAQ: DRTSW) Stock Competitors & Peer Comparison
See DRTSW's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Specialties Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for DRTSW and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| DRTSW | $3.45 | +1.47% | 1.4B | -5.42 | -$0.65 | N/A |
| ALC | $75.28 | +8.25% | 35B | 22.58 | $3.18 | +0.49% |
| STE | $239.12 | +0.69% | 23.3B | 22.95 | $10.42 | +1.06% |
| BRKRP | $423.42 | +5.76% | 8.4B | 228.14 | $1.84 | +0.35% |
| SI | $20.50 | -0.46% | 434.7M | -10.95 | -$1.91 | N/A |
| MOBI | $12.83 | +4.86% | 423.3M | -0.68 | -$18.78 | N/A |
| MASS | $9.73 | +9.57% | 361M | -14.67 | -$0.60 | N/A |
| EDAP | $4.76 | -0.52% | 178.2M | -5.80 | -$0.82 | N/A |
| APYX | $3.28 | -19.12% | 145.7M | -15.73 | -$0.22 | N/A |
| NYXH | $1.59 | +8.16% | 62.6M | -0.63 | -$2.52 | N/A |
Stock Comparison
Alcon Inc. (NYSE: ALC)
DRTSW vs ALC Comparison August 2026
Alpha Tau Medical Ltd. (NASDAQ: DRTSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRTSW stands at 1.4B. In comparison, ALC has a market cap of 35B. Regarding current trading prices, DRTSW is priced at $3.45 on the NASDAQ, while ALC trades at $75.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRTSW currently has a P/E ratio of -5.42, whereas ALC's P/E ratio is 22.58. In terms of profitability, DRTSW's ROE is -0.73%, compared to ALC's ROE of +0.04%. Regarding short-term risk, DRTSW is more volatile compared to ALC. This indicates higher risk in terms of short-term price fluctuations for DRTSW.Check ALC's competition here
STERIS plc (NYSE: STE)
DRTSW vs STE Comparison August 2026
Alpha Tau Medical Ltd. (NASDAQ: DRTSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRTSW stands at 1.4B. In comparison, STE has a market cap of 23.3B. Regarding current trading prices, DRTSW is priced at $3.45 on the NASDAQ, while STE trades at $239.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRTSW currently has a P/E ratio of -5.42, whereas STE's P/E ratio is 22.95. In terms of profitability, DRTSW's ROE is -0.73%, compared to STE's ROE of +0.11%. Regarding short-term risk, DRTSW is more volatile compared to STE. This indicates higher risk in terms of short-term price fluctuations for DRTSW.Check STE's competition here
Bruker Corporation (NASDAQ: BRKRP)
DRTSW vs BRKRP Comparison August 2026
Alpha Tau Medical Ltd. (NASDAQ: DRTSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRTSW stands at 1.4B. In comparison, BRKRP has a market cap of 8.4B. Regarding current trading prices, DRTSW is priced at $3.45 on the NASDAQ, while BRKRP trades at $423.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRTSW currently has a P/E ratio of -5.42, whereas BRKRP's P/E ratio is 228.14. In terms of profitability, DRTSW's ROE is -0.73%, compared to BRKRP's ROE of -0.03%. Regarding short-term risk, DRTSW is more volatile compared to BRKRP. This indicates higher risk in terms of short-term price fluctuations for DRTSW.Check BRKRP's competition here
Shoulder Innovations, Inc. (NYSE: SI)
DRTSW vs SI Comparison August 2026
Alpha Tau Medical Ltd. (NASDAQ: DRTSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRTSW stands at 1.4B. In comparison, SI has a market cap of 434.7M. Regarding current trading prices, DRTSW is priced at $3.45 on the NASDAQ, while SI trades at $20.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRTSW currently has a P/E ratio of -5.42, whereas SI's P/E ratio is -10.95. In terms of profitability, DRTSW's ROE is -0.73%, compared to SI's ROE of -0.24%. Regarding short-term risk, DRTSW is more volatile compared to SI. This indicates higher risk in terms of short-term price fluctuations for DRTSW.Check SI's competition here
Mobia Medical, Inc. Common Stock (NASDAQ: MOBI)
DRTSW vs MOBI Comparison August 2026
Alpha Tau Medical Ltd. (NASDAQ: DRTSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRTSW stands at 1.4B. In comparison, MOBI has a market cap of 423.3M. Regarding current trading prices, DRTSW is priced at $3.45 on the NASDAQ, while MOBI trades at $12.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRTSW currently has a P/E ratio of -5.42, whereas MOBI's P/E ratio is -0.68. In terms of profitability, DRTSW's ROE is -0.73%, compared to MOBI's ROE of +0.31%. Regarding short-term risk, DRTSW is more volatile compared to MOBI. This indicates higher risk in terms of short-term price fluctuations for DRTSW.Check MOBI's competition here
908 Devices Inc. (NASDAQ: MASS)
DRTSW vs MASS Comparison August 2026
Alpha Tau Medical Ltd. (NASDAQ: DRTSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRTSW stands at 1.4B. In comparison, MASS has a market cap of 361M. Regarding current trading prices, DRTSW is priced at $3.45 on the NASDAQ, while MASS trades at $9.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRTSW currently has a P/E ratio of -5.42, whereas MASS's P/E ratio is -14.67. In terms of profitability, DRTSW's ROE is -0.73%, compared to MASS's ROE of -0.26%. Regarding short-term risk, DRTSW is more volatile compared to MASS. This indicates higher risk in terms of short-term price fluctuations for DRTSW.Check MASS's competition here
Edap Tms S.a. (NASDAQ: EDAP)
DRTSW vs EDAP Comparison August 2026
Alpha Tau Medical Ltd. (NASDAQ: DRTSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRTSW stands at 1.4B. In comparison, EDAP has a market cap of 178.2M. Regarding current trading prices, DRTSW is priced at $3.45 on the NASDAQ, while EDAP trades at $4.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRTSW currently has a P/E ratio of -5.42, whereas EDAP's P/E ratio is -5.80. In terms of profitability, DRTSW's ROE is -0.73%, compared to EDAP's ROE of -1.49%. Regarding short-term risk, DRTSW is more volatile compared to EDAP. This indicates higher risk in terms of short-term price fluctuations for DRTSW.Check EDAP's competition here
Apyx Medical Corporation (NASDAQ: APYX)
DRTSW vs APYX Comparison August 2026
Alpha Tau Medical Ltd. (NASDAQ: DRTSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRTSW stands at 1.4B. In comparison, APYX has a market cap of 145.7M. Regarding current trading prices, DRTSW is priced at $3.45 on the NASDAQ, while APYX trades at $3.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRTSW currently has a P/E ratio of -5.42, whereas APYX's P/E ratio is -15.73. In terms of profitability, DRTSW's ROE is -0.73%, compared to APYX's ROE of -0.79%. Regarding short-term risk, DRTSW is more volatile compared to APYX. This indicates higher risk in terms of short-term price fluctuations for DRTSW.Check APYX's competition here
Nyxoah S.A. (NASDAQ: NYXH)
DRTSW vs NYXH Comparison August 2026
Alpha Tau Medical Ltd. (NASDAQ: DRTSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRTSW stands at 1.4B. In comparison, NYXH has a market cap of 62.6M. Regarding current trading prices, DRTSW is priced at $3.45 on the NASDAQ, while NYXH trades at $1.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRTSW currently has a P/E ratio of -5.42, whereas NYXH's P/E ratio is -0.63. In terms of profitability, DRTSW's ROE is -0.73%, compared to NYXH's ROE of -1.80%. Regarding short-term risk, DRTSW is more volatile compared to NYXH. This indicates higher risk in terms of short-term price fluctuations for DRTSW.Check NYXH's competition here
Spectral AI, Inc. (NASDAQ: MDAI)
DRTSW vs MDAI Comparison August 2026
Alpha Tau Medical Ltd. (NASDAQ: DRTSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRTSW stands at 1.4B. In comparison, MDAI has a market cap of 54.4M. Regarding current trading prices, DRTSW is priced at $3.45 on the NASDAQ, while MDAI trades at $1.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRTSW currently has a P/E ratio of -5.42, whereas MDAI's P/E ratio is -3.80. In terms of profitability, DRTSW's ROE is -0.73%, compared to MDAI's ROE of +1.79%. Regarding short-term risk, DRTSW is more volatile compared to MDAI. This indicates higher risk in terms of short-term price fluctuations for DRTSW.Check MDAI's competition here
WORK Medical Technology Group Ltd. Class A (NASDAQ: WOK)
DRTSW vs WOK Comparison August 2026
Alpha Tau Medical Ltd. (NASDAQ: DRTSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRTSW stands at 1.4B. In comparison, WOK has a market cap of 5.1M. Regarding current trading prices, DRTSW is priced at $3.45 on the NASDAQ, while WOK trades at $2.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRTSW currently has a P/E ratio of -5.42, whereas WOK's P/E ratio is N/A. In terms of profitability, DRTSW's ROE is -0.73%, compared to WOK's ROE of -0.07%. Regarding short-term risk, DRTSW is more volatile compared to WOK. This indicates higher risk in terms of short-term price fluctuations for DRTSW.Check WOK's competition here
QTREX Quantum Ltd. Warrant (NASDAQ: QTEXW)
DRTSW vs QTEXW Comparison August 2026
Alpha Tau Medical Ltd. (NASDAQ: DRTSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRTSW stands at 1.4B. In comparison, QTEXW has a market cap of 3.5M. Regarding current trading prices, DRTSW is priced at $3.45 on the NASDAQ, while QTEXW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRTSW currently has a P/E ratio of -5.42, whereas QTEXW's P/E ratio is -0.01. In terms of profitability, DRTSW's ROE is -0.73%, compared to QTEXW's ROE of N/A. Regarding short-term risk, DRTSW is more volatile compared to QTEXW. This indicates higher risk in terms of short-term price fluctuations for DRTSW.Check QTEXW's competition here
iTonic Holdings Ltd. (NASDAQ: ITOC)
DRTSW vs ITOC Comparison August 2026
Alpha Tau Medical Ltd. (NASDAQ: DRTSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRTSW stands at 1.4B. In comparison, ITOC has a market cap of 2.7M. Regarding current trading prices, DRTSW is priced at $3.45 on the NASDAQ, while ITOC trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRTSW currently has a P/E ratio of -5.42, whereas ITOC's P/E ratio is -0.93. In terms of profitability, DRTSW's ROE is -0.73%, compared to ITOC's ROE of -0.94%. Regarding short-term risk, DRTSW is more volatile compared to ITOC. This indicates higher risk in terms of short-term price fluctuations for DRTSW.Check ITOC's competition here
bioAffinity Technologies, Inc. (NASDAQ: BIAFW)
DRTSW vs BIAFW Comparison August 2026
Alpha Tau Medical Ltd. (NASDAQ: DRTSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRTSW stands at 1.4B. In comparison, BIAFW has a market cap of 2.1M. Regarding current trading prices, DRTSW is priced at $3.45 on the NASDAQ, while BIAFW trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRTSW currently has a P/E ratio of -5.42, whereas BIAFW's P/E ratio is 0.23. In terms of profitability, DRTSW's ROE is -0.73%, compared to BIAFW's ROE of -2.57%. Regarding short-term risk, DRTSW is more volatile compared to BIAFW. This indicates higher risk in terms of short-term price fluctuations for DRTSW.Check BIAFW's competition here
ENvue Medical, Inc. (NASDAQ: FEED)
DRTSW vs FEED Comparison August 2026
Alpha Tau Medical Ltd. (NASDAQ: DRTSW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRTSW stands at 1.4B. In comparison, FEED has a market cap of 455.5K. Regarding current trading prices, DRTSW is priced at $3.45 on the NASDAQ, while FEED trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRTSW currently has a P/E ratio of -5.42, whereas FEED's P/E ratio is -0.01. In terms of profitability, DRTSW's ROE is -0.73%, compared to FEED's ROE of -0.44%. Regarding short-term risk, DRTSW is more volatile compared to FEED. This indicates higher risk in terms of short-term price fluctuations for DRTSW.Check FEED's competition here